China Resources Jiangzhong released its 2026 interim report. Net profit attributable to the parent in the first half was 491 million yuan, down 5.9% year on year. Operating revenue was 1.932 billion yuan, down 9.8% year on year. Net profit attributable to the parent after deducting non-recurring items was 470 million yuan, down 2.6% year on year. Net operating cash flow was 696 million yuan, up 6.8% year on year. Second-quarter operating revenue was 896 million yuan, down 6.4% year on year, and net profit attributable to the parent was 203 million yuan, down 14.3% year on year. The company said its main business has not undergone major changes, but revenue from some businesses such as prescription drugs declined due to the impact of centralized procurement policies and intensifying market competition.
Jiangzhong Pharmaceutical Co LtdFirst-half net profit fell 5.9% and revenue dropped 9.8% due to centralized procurement and competition.
